Cargando…
Role of mucolytics in the management of COPD
There is, to date, no medical therapy that modifies the decline in lung function that occurs in COPD. As the disease becomes more severe, exacerbations of COPD become increasingly common, affecting patient quality of life and increasing health care costs. Mucolytic agents, through their actions on i...
Autor principal: | Poole, Phillippa J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706615/ https://www.ncbi.nlm.nih.gov/pubmed/18046889 |
Ejemplares similares
-
Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action
por: Pace, Elisabetta, et al.
Publicado: (2022) -
Efficacy of mucolytics and steam therapy in the management of sinusitis among Indians
por: S Balakrishnan, Rajalakshmi, et al.
Publicado: (2023) -
New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach
por: Juergens, Lisa Joy, et al.
Publicado: (2020) -
Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy
por: Bianco, Andrea, et al.
Publicado: (2022) -
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
por: Cazzola, Mario, et al.
Publicado: (2020)